Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) will release financial results for its Fiscal 2023 Second Quarter, which ended Aug. 27, 2022, on Thursday, Sept. 29. The company will hold an analyst call at 8:30 a.m. ET with remarks by Rite Aid's management team. The call will be broadcast at https://investors.riteaid.com. The telephone replay will be available beginning at 12:00 p.m. ET on Thursday, Sept. 29 through 11:59 p.m. ET on October 31. To access the replay of the call,

Rite Aid to Release Second Quarter Results on September 29

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced that scheduling is now available for the updated boosters of the mRNA Pfizer and Moderna COVID-19 vaccines at its locations and at Bartell Drugs locations in the Pacific Northwest. “At Rite Aid, we recognize the important role pharmacists continue to play in helping our communities fight COVID-19, and we look forward to providing our customers this updated booster which is designed to protect against the original strains and Om

Scheduling for COVID-19 Boosters Now Available at Rite Aid and Bartell Drugs Locations

PHILADELPHIA & YORK, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) and WellSpan Health, an integrated health system serving central Pennsylvania and northern Maryland, today announced they have established a partnership to improve health outcomes for WellSpan's patient population. Together, Rite Aid and WellSpan Health will share data and insights to close gaps in care and improve continuity across a broader continuum of services, increase immunizations, strengthen medication adherence, and promot

Rite Aid and WellSpan Health Join Forces to Support Central Pennsylvania

Drugstore operator Rite Aid Corporation (NYSE: RAD) stock is down (-38%) on the year but has bounced over 40% off its $4.68 low in May.

Could Rite Aid Be an Acquisition Target, Again?

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) today announced that Heyward Donigan, president and chief executive officer, and Matt Schroeder, chief financial officer, will host a virtual retail shareholder investor event at 11 a.m. ET, Aug. 24. The call will be broadcast via the Internet at https://investors.riteaid.com. “We look forward to engaging with our retail shareholders in this new event customized for their specific interests and questions,” Donigan said. “We are com

Rite Aid to Host Retail Shareholder Webcast Event on August 24, 2022

PHILADELPHIA--(BUSINESS WIRE)--It's not too early to schedule your flu shot. Rite Aid (NYSE: RAD) has opened online scheduling for flu shots at its locations including Bartell Drugs in the Pacific Northwest, and is now accepting walk-ins, providing convenient options for families to get vaccinated. “With children going back to school, now is the perfect time to schedule a flu shot as well as other needed routine vaccines,” said Karen Staniforth, Chief Pharmacy Officer at Rite Aid. “More than ev

Rite Aid Opens Online Scheduling for Flu Vaccines at All Locations

Rite Aid (RAD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Rite Aid (RAD) Moves 7.9% Higher: Will This Strength Last?

The pharmacy chain could still be the target of activist investors.

Why Rite Aid Stock Rallied on Friday

Source: Michael Gordon / Shutterstock.com Rite Aid (NYSE: RAD ) stock is heading higher on Friday as speculation about activist investors turning the company around spreads online. The latest talk suggests that management changes at the battered pharmacy chain could single involvement from activist investors.

Are Activists About to Turn Rite Aid (RAD) Stock Around?

ERO Copper Corp

Fastly

Heritage Insurance Hlds

Hydrofarm Holdings Group

Wheels Up Experience

Warby Parker

Although small-cap stocks to buy are risky, they can also yield tremendous gains as they're largely focused on growth narratives. The post 7 Small-Cap Stocks to Buy on the Dip appeared first on InvestorPlace.

7 Small-Cap Stocks to Buy on the Dip

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today published its fourth annual Environmental, Social and Governance (ESG) Report, detailing the company's strategy and progress against goals over the past year. This year's report addresses the four ESG pillars introduced in the company's 2021 report: Thriving Planet, Thriving Business, Thriving Workplace and Thriving Community. “As a purpose-driven healthcare organization, we recognize the need to do our part in minimizing our environment

Rite Aid Releases Fourth Annual Environmental, Social and Governance Report

Quest Diagnostics

PHILADELPHIA & SECAUCUS, N.J.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced it is collaborating with Quest Diagnostics (NYSE: DGX) to provide access to quality, COVID-19 molecular testing (polymerase chain reaction or similar nucleic acid amplification test) to help Rite Aid customers detect and prevent the spread of COVID-19. Quest is the world's leading provider of diagnostic information services and a national leader in COVID-19 testing. The company has performed more than 69 millio

Rite Aid and Quest Diagnostics Expand Access to COVID-19 PCR Testing Nationwide

PHILADELPHIA--(BUSINESS WIRE)--Today, Rite Aid (NYSE: RAD) unveiled its new headquarters in Philadelphia's thriving Navy Yard district. The Rite Aid Collaboration Center, located on the second floor of 1200 Intrepid Avenue, will bring Rite Aid's remote corporate workforce and associates together in a modern space with state-of-the-art amenities. The new headquarters, with its accessibility to major transportation, offers teams across Rite Aid's various businesses – including Rite Aid retail pha

Rite Aid Opens New Modern Headquarters in Philadelphia's Navy Yard

PHILADELPHIA--(BUSINESS WIRE)--Elixir, a wholly owned subsidiary of Rite Aid (NYSE: RAD), announced the launch of a specialty generic medication enhancement to its managed copay solutions effective June 1, 2022. The enhancement allows members to receive generic versions of certain specialty medications at a $0 copay and has the potential to provide an average savings of up to $40,000 annually. “As specialty drug costs continue to climb and account for a significant amount of drug spend, Elixir

Elixir Launches Specialty Generic Enhancement that Leads to Thousands in Annual Savings for Plan Sponsors and Members

Block

Fear of falling tech stocks and crypto is deterring people from buying SQ stock, but savvy investors shouldn't ignore this opportunity. The post Block Stock Traders Are Ignoring the Rite-Aid Collab, but Shouldn't appeared first on InvestorPlace.

Block Stock Traders Are Ignoring the Rite-Aid Collab, but Shouldn't

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) announced today the early tender results of its previously announced series of tender offers (the “Tender Offers”) to purchase for cash certain of its outstanding series of senior notes listed in the table below (collectively, the “Notes”) for an aggregate purchase price, excluding accrued and unpaid interest, of up to $150,000,000 (the “Maximum Aggregate Cap”). The Tender Offers are being made pursu

Rite Aid Announces Early Results of Cash Tender Offers for Outstanding Debt Securities

Rite Aid's (RAD) Q1 results gain from higher sales of non-COVID-19 prescriptions and continued momentum at Elixir. Management raises its revenue guidance for fiscal 2023.

Rite Aid (RAD) Q1 Loss Narrower Than Expected, Revenues Beat

The pharmacy chain's earnings report was just what the doctor ordered.

Why Rite Aid Stock Soared on Thursday

Rite Aid Corporation (NYSE:RAD ) Q1 2023 Results Conference Call June 23, 2022 8:30 AM ET Company Participants Byron Purcell - Investor Relations Heyward Donigan - President & CEO Matt Schroeder - EVP & CFO Andre Persaud - EVP & CRO, Elixir Chris DuPaul - COO, Elixir Conference Call Participants George Hill - Deutsche Bank Elizabeth Anderson - Evercore William Reuter - Bank of America Karru Martinson - Jefferies Jenna Giannelli - Goldman Sachs Carla Casella - JPMorgan Operator Good morning. My name is Regina, and I will be your conference operator today.

Rite Aid Corporation (RAD) CEO Heyward Donigan on Q1 2023 Results - Earnings Call Transcript

Rite Aid (RAD) stock is running higher Thursday morning after the company revealed its earnings report for the fiscal first quarter of 2023. The post Rite Aid (RAD) Stock Pops on Q1 Revenue Beat appeared first on InvestorPlace.

Rite Aid (RAD) Stock Pops on Q1 Revenue Beat

Shares of Rite Aid Corporation (NYSE:RAD) were last seen 9.5% higher to trade at $7.35, following an upbeat first-quarter earnings report.

Options Traders Target Rite Aid Stock After Beat-and-Raise

Rite Aid (RAD) delivered earnings and revenue surprises of 14.29% and 5%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?

Rite Aid (RAD) Reports Q1 Loss, Tops Revenue Estimates

Rite Aid Corp (NYSE: RAD) shares are trading higher Thursday after the company announced better-than-expected financial results and raised full-year revenue guidance above analyst estimates. Rite Aid reported fiscal first-quarter revenue of $6.01 billion, which beat the estimate of $5.75.

Why Rite Aid Stock Is Rising Today

Rite Aid Corp (NYSE: RAD) has reported Q1 FY23 sales of 6.01 billion, down 2.4% Y/Y, beating the consensus of $5.75 billion.  The company reported an EPS loss of $(0.60) compared to an income of $0.38 a year ago, driven by non-cash impairment charges and cycling prior-year COVID.

Rite Aid Shares Jump After Upbeat Annual Guidance

The pharmacy chain reported a smaller loss than Wall Street had penciled in. Sales were higher than expected.

News for Rite Aid Stock (RAD)